Skip to Content

MD Anderson Events

Ethics Seminar Series: The 'Myriad' Dilemma: Should We Be Able To Patent Our Genes?

Ethics Seminar Series: The 'Myriad' Dilemma: Should We Be Able To Patent Our Genes?

The session will consider how healthcare professionals sometimes encounter ethical challenges in their practice. These individuals will gain insight into the current debate involving the nexus between the drive to provide innovative therapies and better patient outcomes with the incentives for health care entrepreneurship and remuneration. At the core of this intellectual property policy debate is the impact and reliance we have on technology/diagnostics as well as the fundamental question of "do we own our bodies?" This presentation will explore some of these issues and open a discussion to address them for social workers, physicians, nurses and ethicists.


·         Identify potential ethical dilemmas that may result from emotional, religious/cultural or value based differences (knowledge).
·         Implement methods discussed in this forum to prevent difficult situations by addressing questions and needs earlier in the patient's care (knowledge, competence, performance, patient outcomes).
·         Integrate the knowledge gained into an interdisciplinary approach to cancer care resulting in practice improvement and increased patient and provider satisfaction (knowledge, competence, performance, patient outcomes).

Date: 6/11/13, 12pm to 1pm
Time: 6/11/13, 12pm to 1pm
Location: FCT3.5001
Directions: Pickens Academic Tower
Format: Seminar/Conference
CME: The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit TM
Facilitator: Jessica A. Moore, DHCE
Speaker: Jeff Farroni, PhD, JD
Contact: Brittany Campbell - (713) 794-1495 -
  Ethics Seminar Announcment_ June 2013.pdf (PDF, 518 KB)